The global point-of-care molecular diagnostics market size was valued at USD 7,232.2 million in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 3.1% from 2023 to 2030. Rising demand for rapid tests along with large number of new product launches for point-of-... Read More »
March 2023The global immunofluorescence assay market size was valued at USD 3,958.6 million in 2022 and is anticipated to expand at a CAGR of 5.29% from 2023 to 2030. Immunofluorescence assay (IFA) is a test performed on biological samples to detect specific antigens in any biological sample or sp... Read More »
March 2023The global vitamin D testing market size was estimated at USD 848.80 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.53% from 2023 to 2030. The market is witnessing growth due to the factors such as the increasing prevalence of osteoporosis, rickets... Read More »
March 2023The global genetic testing market size was valued at USD 7,421.08 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 22.0% from 2023 to 2030. Factors such as increasing awareness of newborn screening and the rising prevalence rate of genetic disorders ar... Read More »
March 2023The global immunoassay for neurological biomarkers market size was valued at USD 601.52 million in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 17.8% % from 2023 to 2030. Immunoassays are protein-based tests that work by quantification and detection of antigen–antibodies interac... Read More »
March 2023The global DNA microarray market size was valued at USD 1,835.54 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.5% from 2023 to 2030. The rising prevalence of cancer, the rapidly evolving information & software technology, and emerging bioinfor... Read More »
February 2023The global ELISA analyzer market size was valued at USD 567.88 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.7% from 2023 to 2030. ELISA (Enzyme-linked Immunosorbent Assay) analyzers is a widely used diagnostic tool that allows for detecting and m... Read More »
February 2023The global label-free array systems market size was valued at USD 455.91 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.42% from 2023 to 2030. The increasing demand for personalized medicine, as well as a variety of other factors such as the preval... Read More »
February 2023The U.S. infectious respiratory disease diagnostics market size was valued at USD 21,630.4 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of -10.1% from 2023 to 2030. Growing incidence of infectious respiratory diseases, such as pneumonia, tuberculosis,... Read More »
February 2023Self-test/kits are utilized for the rapid diagnostics in various disorders. Recently, there are various types of self-testing kits are available in the market. These kits are simple and quick tests for ovulation. In addition, individuals can also monitor blood pressure as well as test fo...Read More »
The growth of the pancreatic cancer diagnostic market is attributed to the increasing disease prevalence coupled with a higher mortality rate, technological advancements in diagnostics tests, and increasing awareness among people about early diagnosis of diseases. According to WCRF Inter...Read More »
The growth of the Antimicrobial Susceptibility Testing (AST) market can be attributed to the increasing incidence of infectious diseases, high antimicrobial resistance, and favorable government initiatives to decrease the burden of infectious diseases. Increasing cases of targeted diseas...Read More »
The home care testing market is allowing consumers to gain control over every day well-being. Test kits that are easily accessible and affordably priced and can be purchased over the counter or online deliver quick findings without the need for conventional referrals and, in many cases, ...Read More »
Genetic test have traditionally been interpreted or ordered in a medical or clinical research setting. However, the last few years has witnessed a high growth in DTC genetic tests that offer consumers with the opportunity to learn about genetic profiles without participation of healthcar...Read More »
The North America point of care diagnostics market size was valued at USD 17.53 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2030. Point-of-care (POC) diagnosis refers to performing diagnostic tests at the site of the patient. The... Read More »
January 2023The global rapid tests market size was valued at USD 1.29 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.6% from 2023 to 2030. The growing geriatric population, rising target disease burden, and increasing adoption of self-testing & point-of-ca... Read More »
January 2023The North America in vitro diagnostics market size was valued at USD 50.16 billion in 2022 and is expected to decline at a compound annual growth rate (CAGR) of 2.89% from 2023 to 2030. The decline in demand for COVID-19 infection detection tests is projected to hamper the growth over th... Read More »
January 2023The South East Asia COVID-19 molecular diagnostics market size was valued at USD 2.27 billion in 2022 and is expected to decline at a compound annual growth rate (CAGR) of -5.20% from 2023 to 2030. Declining cases of COVID-19 in the region coupled with an increasing vaccinated population... Read More »
January 2023The global in-vitro toxicology testing market size was valued at USD 28,014.0 million in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 11.10% from 2023 to 2030. The major factor boosting the growth of in-vitro toxicology testing market is the developments in ... Read More »
January 2023The U.S. cancer biopsy market size was estimated at USD 8.68 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 11.12% by 2030. The U.S. cancer biopsy market is witnessing growth due to the factors such as advancements in quality & payment pertaining... Read More »
January 2023The global vacuum blood collection tube market size was valued at USD 2.98 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 3.02% from 2023 to 2030. Vacuum blood collection tubes are also known as vacutainers. The tube comprises a plastic adapter at... Read More »
January 2023The global body fluid collection and diagnostics market size was valued at USD 30.19 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2030. Rapid results, cost-effectiveness, and early prognosis of diseases are some of the factors co... Read More »
December 2022The global in situ hybridization market size was valued at USD 1.44 billion in 2022 and it is expected to expand at a compound annual growth rate (CAGR) of 6.9% from 2023 to 2030. In-situ hybridization has become an important process to identify, localize, and detect the specific DNA seq... Read More »
December 2022The global liver cancer diagnostics market size was valued at USD 8,718.8 million in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 6.67% by 2030. Around the world, liver cancer is among the leading cause of cancer-related deaths. As per the American Cancer ... Read More »
December 2022Carrier screening is performed to diagnose a genetic disorder. It is a genetic test conducted on the patient to identify the gene responsible for a genetic disorder or abnormal chromosomal disorder. It is also performed on the pregnant woman to find out whether the child has the disorder... Read More »
December 2022The global kidney function tests market size was valued at USD 845.9 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.50% from 2023 to 2030. Various factors, such as increasing investments by market players, rising R&D activities, high prevalence... Read More »
December 2022Italy in vitro diagnostics market size was valued at USD 4,361.79 million in 2022 and is expected to decline at a compound annual growth rate (CAGR) of -1.90% from 2023 to 2030. The exponential decline in demand for IVD products for the detection of COVID-19 infection in the coming years... Read More »
December 2022The global meningitis diagnostic testing market size was valued at USD 115.41 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 3.68% from 2023 to 2030. The increasing prevalence of meningitis and increasing favorable initiatives to combat the disease wit... Read More »
November 2022The global cell viability assays market was valued at USD 1.39 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 9.94% from 2023 to 2030. Cell viability is defined as the existence of living or viable cells and is considered an indicator of good cell he... Read More »
November 2022Drug discovery and development have evolved drastically in the recent past and continue to trend with emerging advancements. Innovative and sophisticated approaches are being incorporated with novel modalities emerging continuously through multifaceted approaches....Read More »
Breast cancer core needle biopsy uses a hollow needle to remove a tube-shaped piece of tissue with a spring-loaded or vacuum-powered system. The tissue sample is used further for a more accurate laboratory assessment for precise determination of carcinogenicity. Growing incidence of brea...Read More »
The global endocrine testing market size was valued at USD 2,355.4 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 8.31% from 2022 to 2030. The prevalence of diabetes, thyroid, and obesity worldwide has resulted in government funding initiatives for inc... Read More »
November 2022The global personalized medicine biomarkers market size was estimated at USD 11.76 billion in 2021. It is expected to expand at a compound annual growth rate (CAGR) of 15.51% from 2022 to 2030. The growth can be attributed to the increasing demand for personalized medicine, the increasin... Read More »
November 2022The global latent tuberculosis infection detection market size was valued at USD 1,342.2 million in 2021 and is expected to witness a compound annual growth rate (CAGR) of 5.6% from 2022 to 2030. Factors such as the increasing risk of developing active tuberculosis and increasing awarene... Read More »
November 2022The global breast cancer liquid biopsy market size was estimated at USD 277.00 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 22.7% by 2030. The growth can be attributed to factors such as the increasing prevalence of breast cancer among the populati... Read More »
November 2022The global antimicrobial resistance diagnostics market size was valued at USD 3.9 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2022 to 2030. High disease burden from pathogens such as streptococcus pneumonia, MRSA, C. difficile infections... Read More »
November 2022The global saliva collection and diagnostics market size was valued at USD 804.7 million in 2021 and is projected to witness a compound annual growth rate (CAGR) of 8.4% from 2022 to 2030. The growth of the market is attributed to factors such as the increasing need for rapid diagnosis o... Read More »
November 2022The global urinalysis market size was valued at USD 3,550.2 million in 2021 and is expected to witness a compound annual growth rate (CAGR) of 4.6% from 2022 to 2030. Urinalysis market is witnessing growth due to the factors such as the rising incidence of diseases such as Urinary Tract ... Read More »
October 2022The global gastrointestinal diagnostics market size was valued at USD 4.59 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.58% from 2022 to 2030. Factors such as the increasing demand for POC testing for gastrointestinal disorders and the rising pre... Read More »
October 2022The global cancer diagnostics market size was valued at USD 160.5 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.89% from 2022 to 2030. Increasing number of cancer cases globally is one of the major factors contributing to industry growth during th... Read More »
October 2022The global nucleic acid amplification testing market was valued at USD 6,199.2 million in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 12.78% from 2022 to 2030. Increase in demand for the advanced rapid diagnostics and rising R&D investments for the de... Read More »
October 2022The global pharmaceutical sterility testing market size was valued at USD 1,270.2 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 11.5% from 2022 to 2030. Government investments in the healthcare industry, increasing R&D activities, a surge in the... Read More »
October 2022The global influenza diagnostics market size was valued at USD 1.07 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 3.5% from 2022 to 2030. The industry has witnessed constant changes in its trend.... Read More »
October 2022The global proteinase K market size was valued at USD 3.62 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.84% from 2022 to 2030. Increasing implementation of cell separation techniques by cell banks, diagnostic labs, and research laboratories and i... Read More »
October 2022The Canada latent tuberculosis infection detection market size was valued at USD 27.31 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 6.2% from 2022 to 2030. The market growth is mainly driven by the increasing immigration in Canada and increasing awar... Read More »
October 2022The global monkeypox testing market size was estimated at USD 1.79 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.35% from 2022 to 2030. The market is expected to reach USD 184.11 million in 2022 attributable to the surge in cases of monkeypox glob... Read More »
September 2022The global cellular health screening market size was valued at USD 2.55 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2022 to 2030. Over the projected period, the importance of precision medicine is expected to increase along with the requ... Read More »
September 2022The global infectious respiratory disease diagnostics market size was estimated at USD 63.7 billion in 2021 and is expected to decline at a compound annual growth rate (CAGR) of - 1.8% from 2022 to 2030. This can be attributed to a decline in COVID-19 test... Read More »
September 2022The global infectious disease in vitro diagnostics market size was estimated at USD 113.61 billion in 2021 and is expected to decline at a compound annual growth rate (CAGR) of - 7.4% from 2022 to 2030. The decline in CAGR is only due to the impact of the COVID-19 pandemic. However,... Read More »
August 2022The global non invasive prenatal testing market size was valued at USD 3.80 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 9.61% from 2023 to 2030. High demand for early Non Invasive Prenatal Testing (NIPT) and improvements in the reimbursement scena... Read More »
August 2022The global multi cancer early detection market was valued at USD 856.14 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 15.80% from 2023 to 2030. The market for multi cancer early detection (MCED) is expected to witness growth due to the factors ... Read More »
August 2022The global central lab market size was valued at USD 31.10 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 6.50% from 2023 to 2030. The growth can be attributed to the increasing investment in R&D and increased focus of sponsors & investig... Read More »
August 2022The U.S. in vitro diagnostics market size was valued at USD 46.90 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of -3.27% from 2023 to 2030. The exponential reduction in demand for in vitro diagnostics (IVD) in the diagnosis of SARS-CoV-2 infection dur... Read More »
July 2022The global polymerase chain reaction market size was valued at USD 36.84 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of -9.30% from 2023 to 2030. A significant decline in the industry growth is anticipated to decrease the demand for diagnostic tests ... Read More »
July 2022The global cardiac biomarkers market size was valued at USD 13.98 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 14.7% from 2022 to 2030. Cardiac biomarkers are witnessing growth owing to factors such as the high prevalence of acute coronary syndrome... Read More »
July 2022The India malaria diagnostics market size to be valued at USD 27.5 million by 2026 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% during the forecast period. In India, malaria is primarily caused by Plasmodium vivax and Plasmodium falciparum. P. vivax is mos... Read More »
July 2022The global drug testing market size to be valued at USD 11.7 billion by 2028 and is expected to grow at a compound annual growth rate (CAGR) of 4.9% during the forecast period. Stringent regulations by government agencies mandating alcohol and drug testing for safety purposes and increas... Read More »
July 2022The UAE genetic testing market size was valued at USD 29.27 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 21.40% by 2030. The growth is majorly attributed to the rising prevalence of genetic conditions, increasing investments in genetic R&D... Read More »
July 2022The global qPCR instruments market size to be valued at USD 1.39 billion by 2028 and is expected to grow at a compound annual growth rate (CAGR) of 3.4% during the forecast period. The growing prevalence of diseases, technological advancements, and increasing demand for qPCR instruments ... Read More »
July 2022The global urinary tract infection testing market size was estimated at USD 553.91 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.1% from 2022 to 2030. The UTI testing market is witnessing growth due to factors such as rising disease burden, rapid ... Read More »
July 2022The global real-time PCR, digital PCR, and end-point PCR market size was valued at USD 31.64 billion in 2021 and is expected to decline at a compound annual growth rate (CAGR) of 8.2% from 2022 to 2030. The decrease in the demand for PCR testing for COVID-19 testing is expected to declin... Read More »
June 2022The global blood group typing market size to be valued at USD 3.44 billion by 2026, expanding at a compound annual growth rate (CAGR) of 9.7% during the forecast period. Rising use of blood group typing in prenatal testing and forensic sciences, rising number of blood transfusions due to the number of road... Read More »
June 2022The global point of care diagnostics market size was valued at USD 40.61 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.50% from 2023 to 2030. The market is set to gain momentum in the coming years on account of the increase in funding from mu... Read More »
May 2022The global in vitro diagnostic market size was valued at USD 132.95 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of -2.8 % from 2023 to 2030. The growth can be attributed to the increasing adoption of IVDowing to the rise in testing due to the pan... Read More »
May 2022The global hereditary testing market size was valued at USD 6.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2022 to 2030. The expanding reproductive genetic health space is one of the key market drivers. Key players such as Natera have r... Read More »
May 2022The global malaria diagnostics market size was valued at USD 728.8 million in 2021 and is anticipated to witness a CAGR of 5.4% during the forecast period. The rising demand for malaria diagnostics and the introduction of novel diagnostic techniques are the key factors driving the market... Read More »
May 2022The global COVID-19 sample collection kits market size was valued at USD 6.48 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.7% from 2022 to 2030. SARS-CoV-2 sampling is the most critical step in the effective diagnosis of active infection.... Read More »
May 2022The global COVID-19 diagnostics market size was valued at USD 97.4 billion in 2021 and is expected to decline at a compound annual growth rate (CAGR) of 7.7% from 2022 to 2030. The market is driven by rising government initiatives targeted toward the implementation of mass testing.... Read More »
May 2022The global molecular diagnostics market size was valued at USD 37.04 billion in 2021 and is expected to decline at a compound annual growth rate (CAGR) of -1.6% from 2022 to 2030. The shrinking of the market can be attributed to the decline in demand for molecular COVID-19 testing during... Read More »
April 2022The global neglected tropical diseases (NTD) diagnosis market size was valued at USD 6.09 billion in 2021 and is expected to expand at a CAGR of 4.4% during the forecast period. Growing awareness of NTDs and an increasing number of initiatives undertaken by the government are anticipated... Read More »
April 2022The global blood transfusion diagnostics market size was valued at USD 3,713.7 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.6% from 2021 to 2027. This growth can be attributed to the increasing rate of approval by the U.S. FDA for blood transfusi... Read More »
November 2021The global anatomic pathology market size was valued at USD 16.06 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 10.08% from 2021 to 2028. An increase in the clinical use of biomarkers enables the pathologists to determine disease pathogenesis at the... Read More »
November 2021The global C-reactive protein testing market size was valued at USD 5.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 0.3% from 2021 to 2028. Advancements in nanotechnological tools are expected to provide a lucrative perspective in designing portab... Read More »
October 2021The global liquid biopsy market size was valued at USD 7.03 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 13.5% during the forecast period. The increasing prevalence of cancer coupled with the rise in demand for fast, minimally invasive diagnostic tes... Read More »
October 2021The global histology and cytology market size was valued at USD 12.35 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 14.74% from 2021 to 2028. An increase in the demand for the detection of cell and tissue characteristics and a global increase in the... Read More »
September 2021The global neurological biomarkers market size was valued at USD 6.1 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 12.9% from 2020 to 2028. The market growth can be attributed to a rise in the prevalence of neurological diseases, such as migraines, de... Read More »
September 2021The global infectious disease molecular diagnostics market size was valued at USD 32.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 3.0% from 2020 to 2028. The growth can be attributed to the growing use of molecular diagnostics in infection detect... Read More »
September 2021The global cancer biopsy market size was valued at USD 21.26 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.13% from 2021 to 2027. The increasing prevalence of oncology indications, coupled with the growing geriatric population, is a major factor ... Read More »
July 2021The global lab automation market size was estimated at USD 4.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.1% from 2021 to 2028. Lab automation uses technology to substitute or streamline the manual manipulation of processes and equipment. Depen... Read More »
July 2021The global chemiluminescence immunoassay market size was valued at USD 7.34 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.9% from 2021 to 2028. Chemiluminescence immunoassay (CLIA) solutions are widely applied in the detection of chronic diseases,... Read More »
July 2021The global COVID-19 antigen test market size was valued at USD 5.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2021 to 2027. The COVID-19 antigen tests are gaining traction in the current scenario, as it is easy to use, patient-friendly,... Read More »
July 2021The Europe immunoassay analyzers market size was valued at USD 1.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.0% from 2021 to 2028. Immunoassays play a vital role in disease diagnosis and treatment planning. Thus, an increase in the prevalence ... Read More »
June 2021The U.S. tissue diagnostics market size was valued at USD 2.07 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 3.91% from 2021 to 2028. The market is collectively driven by emerging solutions pertaining to digital tissue diagnostics, advancements in ima... Read More »
June 2021The global COVID-19 saliva screening test potential market size was valued at USD 2955.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.8% from 2021 to 2023. These estimates represent a potential market size for the COVID-19 saliva screening test i... Read More »
June 2021The global HPV testing and Pap test market size was valued at USD 1.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 16.4% from 2021 to 2028. Technological advancements, increasing number of cervical cancer screening programs, and high incidence of c... Read More »
May 2021The global blood testing market size was valued at USD 73.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.3% from 2021 to 2028. Growing medical spending by the government and regulatory bodies is expected to drive the market during the forecast pe... Read More »
May 2021The global breast cancer diagnostics market size was valued at USD 3.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.0% from 2021 to 2028. The growth can be attributed to the increasing prevalence of cancer and rising government initiatives to inc... Read More »
April 2021The global drug of abuse testing services market size was valued at USD 2.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.2% from 2021 to 2028. An increase in the consumption of alcohol and illicit drugs has led to the high growth of the market. T... Read More »
February 2021The global rapid medical diagnostic kits market size was valued at USD 13.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 3.4% from 2021 to 2028. The market for rapid medical diagnostic kits is set to gain momentum in the coming years owing to the r... Read More »
February 2021The global laboratory proficiency testing market size was valued at USD 1.1 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 7.3% from 2020 to 2027. The growth can be attributed to the increasing adoption of laboratory proficiency testing owing to stri... Read More »
January 2021The global in-vitro diagnostics enzymes market size was valued at USD 706.97 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 8.97% from 2020 to 2027. Enzymes are adopted in the diagnosis of various metabolic disorders owing to their remarkable catalyt... Read More »
November 2020The global hemato oncology testing market size was estimated at USD 2.5 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 14.6% from 2020 to 2027. Hemato oncology is typically referred to as the science associated with the treatment, diagnosis, and prev... Read More »
October 2020The global cervical dysplasia market size was valued at USD 509.2 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 7.3% from 2020 to 2027. Cervical dysplasia occurs when there is precancerous or abnormal cell growth around or in the cervix. The presenc... Read More »
October 2020The global D-dimer testing market size was valued at USD 1.2 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 4.3% from 2020 to 2027. A paradigm shift towards the demand for next-generation point-of-care D-dimer testing has driven the market. This is bec... Read More »
September 2020The global oncology companion diagnostic market size was valued at USD 2.2 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 12.7% from 2020 to 2027. The evolving role of oncology companion diagnostics in the era of next-generation omics is expected to dr... Read More »
September 2020The global bacterial and viral specimen collection market size was valued at USD 13.6 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 14.0% from 2020 to 2027. With an increase in demand for diagnostic testing for COVID-19, several manufacturers have ram... Read More »
September 2020The global COVID-19 detection kits market size is valued at USD 3.28 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 5.05% from 2021 to 2027. Several nations are engaged in the development of kits and apps along with tracking programs for mass test... Read More »
September 2020The global thyroid cancer diagnostics market size was valued at USD 2.4 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 5.5% from 2020 to 2027. Rising prevalence of thyroid cancer and increasing emphasis on early diagnosis and treatment are factors expe... Read More »
June 2020The global liver disease diagnostics market size was valued at USD 29.3 billion in 2019 and is estimated to grow at a compound annual growth rate (CAGR) of 6.5% from 2020 to 2027. Rising prevalence of acute and chronic liver diseases is one of the major factors expected to drive the mark... Read More »
June 2020The global cannabis testing services market size was valued at USD 1.1 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 15.4% from 2020 to 2027. The leading factor attributing to market growth is the growing need for cannabis testing services due to a ri... Read More »
May 2020The global prostate cancer diagnostics market size was valued at USD 2.83 billion in 2019 and is anticipated to expand at a CAGR of 13.2% during the forecast period. Increasing prevalence of prostate cancer is one of the major factors propelling the demand for diagnostic products. Accord... Read More »
February 2020The global tissue diagnostics market size was valued at USD 4.2 billion in 2019 and is expected to register a CAGR of 5.9% over the analysis period. Tissue diagnostics continues to serve as one of the gold standards for cancer diagnosis as these technologies capture the biological contex... Read More »
February 2020The global blood collection market size was valued at USD 8.50 billion in 2018 and is projected to register growth at a CAGR of 6.6% over the forecast period. Increasing prevalence of infectious diseases, mounting number of accident & trauma cases, and non-communicable diseases are t... Read More »
November 2019The U.S. influenza diagnostics market size was valued at USD 109.2 million in 2018 and is anticipated to grow at a CAGR of 5.4% during the forecast period. Influenza which is caused by the influenza virus is commonly known as flu. Influenza virus consists of three types, namely Type A, T... Read More »
October 2019The global helicobacter pylori diagnostics market size was estimated at USD 476.2 million in 2018 and is anticipated to expand at a CAGR of 6.0% over the forecast period. Increasing demand for personalized antibiotic therapy and improved cost-effectiveness of diagnosis of helicobacter py... Read More »
October 2019The global cholesterol testing products and services market size was valued at USD 14.8 billion in 2018 and is expected to witness lucrative CAGR of 7.9% over the forecast period. Growing prevalence of high cholesterol levels is expected to drive the growth. Increasing awareness regardin... Read More »
October 2019Heart failure POC & LOC devices market size was estimated at 45.4 million in 2018 and is projected to grow at a CAGR of 16.2% during the forecast period. Owing to miniaturization, lab-on-chip (LOC) technology exhibits high potential to improve disease diagnosis with respect to cost-e... Read More »
October 2019The global Comprehensive Metabolic Panel (CMP) Testing market size was estimated at USD 10.8 billion in 2018 and is expected to register a CAGR of 7.3% during the forecast period. Factors such as the rising prevalence of chronic diseases and emphasis on early diagnosis and treatment are ... Read More »
September 2019The global ovarian cancer diagnostics market size was estimated at USD 1.2 billion in 2018 and is expected to grow at a CAGR of 6.2% during the forecast period. Rising prevalence of ovarian cancer and increasing emphasis on early diagnosis & treatment are expected to drive market gro... Read More »
July 2019The global predictive genetic testing and consumer genomics market size was estimated at USD 3.4 billion in 2018 and is anticipated to exhibit a CAGR of 13.9% over the forecast period. The broadening horizon of predictive genetic testing as a consequence of increase in the number of... Read More »
June 2019The global sperm bank market size was estimated at USD 4.33 billion in 2018 and is projected to expand at a CAGR of 3.3% over the forecast period. Innovations in cryopreservation techniques, rising awareness, emergence of fertility tourism, and increasing access to infertility treatment ... Read More »
May 2019The global blood culture tests market size was valued at over USD 3.7 billion in 2018 and is anticipated to expand at a CAGR of 9.1% over the forecast period. Growing approval rate of new products, such as instruments and consumables for Bloodstream Infections (BSI) diagnosis, by regulat... Read More »
April 2019The global blood preparation market size was valued at USD 36.7 billion in 2018and is projected to expand at a CAGR of 5.6% from 2019 to 2026. Growing demand for blood and its components in surgical procedures is expected to be a key factor driving the market. According to the Healthcare... Read More »
April 2019The global epigenetics diagnostic market size was valued at USD 5.5 billion in 2018 and is estimated to register a CAGR of 18.8% over the forecast period. Increasing prevalence of cancer and other chronic diseases and the growing geriatric population are some of the key factors expected ... Read More »
April 2019The global Preimplantation Genetic Testing (PGT) (PGS/PGD) market size was estimated at USD 74.72 million in 2018 and is expected to expand at a CAGR of 6.2% over the forecast period. Recent technological advancements have profoundly changed thecurrent practice of prenatal screening and ... Read More »
April 2019The global In-Vitro Diagnostics quality control market size was valued at USD 905 million in 2018 and is anticipated to register a CAGR of 4.1% over the forecast period. An increasing number of accredited clinical laboratories worldwide and the presence of favorable regulatory bodies are... Read More »
March 2019The global rabies diagnostics market size was valued at USD 1.47 billion in 2017 and is projected to expand at a CAGR of 4.1% during the forecast period. Neglected Tropical Diseases (NTDs) have afflicted several densely populated and low-resource setting regions across the globe. One suc... Read More »
February 2019The global hematology diagnostics market size was estimated at USD 5.96 billion in 2017. It is anticipated to expand at a CAGR of 5.85% over the forecast period. The factors such as increasing prevalence of blood disorders coupled with increasing awareness about these disorders, and the ... Read More »
December 2018The global capillary blood collection devices market size was valued at USD 1.27 billion in 2019. It is projected to expand at a CAGR of 5.4% during the forecast period. Rising availability of PoC diagnostics, increasing prevalence of chronic diseases, and various advantages of the produ... Read More »
December 2018The global creatinine measurement market is expected to witness significant growth over the forecast period. Creatinine is an endogenous by-product of muscle metabolism. Clinical laboratory measurement of this waste product is used for the assessment of glomerular filtration rate (GFR) t...Read More »
The global breast lesion localization methods market size was valued at USD 580.7 Million in 2017 and is projected to expand further at a CAGR of 13.3% during the forecast period. Breast cancer is the most prominent and invasive cancer; thus, increasing prevalence of it among women is ex... Read More »
November 2018The North American molecular diagnostics market size was USD 3.66 billion in 2017 and is expected to register a CAGR of 10.4% over the forecast period. Increased adoption of molecular diagnostics (MDx) for infectious diseases, coupled with advent of new cancer diagnostic solutions, is dr... Read More »
November 2018The global antinuclear antibody test market size was valued at USD 923.1 million in 2017. It is projected to expand at a CAGR of 12.5% over the forecast period. High prevalence of autoimmune disorders coupled with awareness regarding these diseases is likely to drive the market over the ... Read More »
October 2018The global disruptive behavior disorder (DBD) treatment market size was valued at USD 15.7 billion in 2017 and is expected to register a CAGR of 4.9% over the forecast period. The market is mainly driven by the growing prevalence of behavioral disorders. Disruptive behavior or externaliz... Read More »
October 2018The global women’s health diagnostics market size was valued at around USD 16.5 billion in 2017. It is expected to expand at a CAGR of 6.9% during the forecast period. Rising prevalence of infectious diseases, such as hepatitis and urinary tract infection, among women is anticipate... Read More »
September 2018The global neuroendocrine carcinoma market is expected to witness lucrative growth over the forecast period due to an increase in the incidence of neuroendocrine tumors (NETs) around the globe. This type of cancer occurs in the neuroendocrine system of the human body and produces hormone...Read More »
The North America and Europe stroke diagnostics market size was valued at USD 1.46 billion in 2016. It is anticipated to witness a CAGR of 6.2% during the forecast period. Stroke is considered as one of the leading causes of mortality and physical disability in North America and Europe. ... Read More »
July 2018The global transplant diagnostics market size was valued at USD 500.1 million in 2016 and is likely to expand at a CAGR of 7.6% over the forecast period. An increasing number of organ transplant procedures is a major factor driving demand for diagnostics used before the procedure. The de... Read More »
June 2018The global clinical microbiology market size was valued at USD 9.1 billion in 2016 and is expected to develop at a CAGR of 6.7% over the forecast period. Constantly rising incidence of infectious diseases is driving market growth. Infectious diseases are primarily diagnosed using clinica... Read More »
June 2018The global hepatitis diagnostic test market size was valued at USD 3.9 billion in 2016 and is expected to grow at a CAGR of 6.5% over the forecast period. Rising prevalence of hepatitis diagnostics is primarily driving the growth of the global market. Data published by the World Health O... Read More »
May 2018The global blood screening market size was valued at USD 1.6 billion in 2015 and is projected to grow at a CAGR of 10.2% over the forecast period. Blood screening is a process in which donated blood is screened for various infectious diseases such as HBV, HCV, HIV1, and HIV2. High growth... Read More »
April 2018The global zika virus Testing market size was valued at USD 131.9 million in 2016. It is projected to exhibit a CAGR of 7.6% over the forecast period. Involvement of international organizations, such as UNICEF, and national governments in low-income developing regions is one of the key t... Read More »
April 2018The global primary care POC diagnostics market size was estimated at USD 6.3 billion in 2016.Rapid evolution of point-of-care testing (POCT) holds enormous potential for the growth of both primary and secondary care settings. Rapidly increasing healthcare expenditure within secondary and... Read More »
March 2018The global newborn screening market size was valued at USD 783.5 million in 2016 and is expected to grow at a CAGR of 10.6% during the forecast period. Growing neonatal population base, rising cases of congenital diseases in newborns, favorable government programs & legislations, and... Read More »
February 2018The Latin America clinical laboratory services market size was estimated at USD 14.4 billion in 2016 and is projected to expand at a CAGR of 7.5% over the forecast period. Rising burden of chronic diseases, coupled with consequent demand for diagnostic tests, is expected to serve as a hi... Read More »
February 2018The global hematologic malignancies market size was valued at USD 35.6 billion in the year 2016 with a CAGR of 10.48%. Growing incidence of blood cancer and increasing focus on the development of new treatments are expected to drive the market. Globally, blood malignancies is the fifth m... Read More »
September 2017The global point of care infectious disease testing market size was estimated at USD 1.05 billion in 2016. Driven by the latest trends of consumer-centric services coupled with high demand for portable and rapid testing devices this market is expected to witness lucrative growth. Moreove... Read More »
August 2017The global Structural Heart Imaging market size was estimated at USD 10.1 billion in 2016. Global increase in incidence of Congenital Heart Diseases (CHDs) and rising government support to improve accessibility to treatments are expected to be major factors driving growth. CHDs represent... Read More »
August 2017The global pharmacogenomics technology market size was estimated at USD 5.62 billion in 2016. Theranostics, are pioneering personalized medicine by predicting prognosis and pinpointing diagnoses down to the subtype of chronic conditions. Rising cost of healthcare coupled with new opportu... Read More »
June 2017The global autoimmune disease diagnostics market size was valued at USD 3.3 billion in the year 2015 and is estimated to reach a value of USD 5.0 billion by 2025, growing with CAGR of 4.1%. Increasing prevalence of autoimmune disorders such as type 1 diabetes in ... Read More »
February 2017The global legionella testing market size was valued at USD 160.0 million in 2015 and is expected to grow at a CAGR of 8.4% during the forecast period. The increasing incidence of Legionella-related disorders and rising awareness about their preventive management is expected to drive the... Read More »
January 2017Atrial septal defect (ASD) is a congenital heart defect in which blood flows between the atria of the heart chamber. Normally, the artria are separated by a dividing wall, the interatrial septum. If this septum is defective or absent then oxygen rich blood can flow directly from the left...Read More »
Arrhythmia is an abnormal heart rhythm. It may feel like fluttering or a brief pause. It may be so brief that it does not change your overall heart rate (the number of times per minute that your heart beats); or it can cause the heart rate to be too slow or too fast. Some arrhythmias do ...Read More »
The U.S. IVD and LDT for autoimmune diseases market was valued at USD 4.0 billion in 2015 and is expected to reach USD 4.74 billion by 2024. The market growth can be attributed to rising occurrence of autoimmune diseases & cancers and technological advances in diagnostic techniques. ... Read More »
November 2016The global cancer biological therapy market is expected to witness significant growth owing to large patient pool. There are also other factors that drive the growth of the market such as growing prevalence of several cancers, growing impact of biosimilar, continuous patent expiry of can...Read More »
The global cervical cancer diagnostic market was valued at USD 7 billion in 2015 and is projected to grow at a CAGR of 5.9% over the forecast period. Women between the age group of 20 and 60 years are usually more prone to this ailment, which is expected to increase the screening and dia... Read More »
September 2016The global tuberculosis diagnostics market was valued at USD 2.1billion in 2015 and is expected to witness a CAGR of 4.1% over the forecast period. The rising burden of tuberculosis is one of the biggest concerns among the government and healthcare agencies.... Read More »
September 2016The Europe molecular diagnostics market size was valued at USD 1,750.0 million in 2015 and is expected to exhibit attractive growth over the forecast period. As a developed region, technology enhancement is enabling the European market to further grow through the development of new produ... Read More »
August 2016The Europe IVD market was valued at USD 12.51 billion in 2015. The growing base of the geriatric population in the European countries, the increasing prevalence of chronic diseases, and the rising awareness among the population for early diagnosis of life-threatening diseases are the hig... Read More »
August 2016The global critical care diagnostic (CCD) market size was estimated at USD 837.6 million in 2015. These diagnostic tests deal with the specialized care and diagnosis of life-threatening diseases occurring in patients.... Read More »
August 2016The Asia Pacific In Vitro Diagnostics market was estimated at USD 12.1 billion in 2015. The increase in number of infectious and chronic diseases, the rising awareness levels of advanced diagnostic solutions as well as technological developments are estimated to be some major factors pro... Read More »
August 2016Latin America's point of care diagnostics market size was valued at USD 1.19 billion in 2015. Hospitals assisted living homecare facilities and other healthcare facilities are noted to have increased adoption rates of POC diagnostics in Latin America to provide rapid and effective diagno... Read More »
August 2016The global Computer Aided Detection (CAD) market size was valued at USD 405.9 million in 2014. Increasing cancer prevalence and rising awareness in the population for regular health check-ups are the most significant drivers of the global CAD industry.... Read More »
August 2016The global lung cancer diagnostics market size was estimated at USD 1.63 billion in 2015. Technological advancements pertaining to tumor diagnosis contribute to market growth. The need for more efficient diagnostic systems is due to the fact that only 15% of the lung cancer cases get dia... Read More »
June 2016The global in-vitro colorectal cancer screening tests market was valued at USD 559.3 million in 2014 and is likely to grow at a CAGR of 5.2% over the forecast period.... Read More »
June 2016The global cancer pain market is expected to post a healthy market growth rate during the forecast period. The steady growth of this market can be attributed to the launch of new products that specifically treat pain-related to cancer. Pain in cancer may come from compressing or infiltra...Read More »
If blood cell counts are low, then the drug given by the doctor is termed as a blood cell growth factor to stimulate blood cell production. The body normally makes blood cells with the help of a hormone produced in the kidneys, called erythropoietin (EPO). The DNA of immature blood ...Read More »
The European Real-time Polymerase Chain Reaction (qPCR) market was valued at over USD 182 million in 2014.... Read More »
February 2016Global STD diagnostics market size was valued at over USD 17 billion in 2014. An increase in patient awareness such as education campaigns and growing government initiatives are anticipated to drive market growth. ... Read More »
January 2016The global HIV diagnostics market was valued at USD 2,173.8 million in 2014 and is expected to grow at a CAGR of 9.5% over the forecast period.... Read More »
January 2016The Europe, Middle East, and Africa (EMEA) Point-of-Care (PoC) diagnostics market size was valued at USD 4,567.2 million in 2014. Growing base of geriatric population coupled with high incidence rates of chronic diseases is one of the major factors fostering the growth of EMEA PoC diagno... Read More »
January 2016The heart attack diagnostics market was estimated to reach USD 6.6 billion in 2015. Heart attack or myocardial infarction is a form of cardiovascular disease (CVD) and it occurs when oxygenated blood flow to the heart muscle is reduced or cut off, which is also termed as myocardial ische... Read More »
July 2015The global automated microbiology market is expected to grow over the forecast period owing to the increasing prevalence of pathogen induced diseases. In the recent years, identification of pathogens with the help of automated microbiology has generated huge momentum, as it helps in earl...Read More »
The global genetic disease diagnostic market is anticipated to witness growth over the forecast period, driven by rising incidences of genetic disorders that give rise to a wide variety of independent diagnostic procedures. Additionally, increasing awareness about prenatal diagnosis, ris...Read More »
The global Infectious disease diagnostics market is expected to grow during the forecast period owing to the increasing prevalence of various infectious diseases such as malaria, TB, HIV/AIDS, hepatitis, HAIs, STDs, and diarrheal diseases. The other vital drivers of this market are the g...Read More »
The global diabetes treatment market is undergoing a significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. There has been a drastic increase in the incidents of diabetes worldwide, owing to the rising level of sedentary lifesty...Read More »
The global astma and COPD market is expected to witness significant growth over the forecast period. Increasing prevalence of respiratory diseases owing to the growing aging population and increasing pathogens in the environment has been the key factor driving asthma and chronic obstruct...Read More »
The rising prevalence of cardiovascular and pulmonary disorders such as arrhythmia and heart valve imbalance are the major factors driving the cardiopulmonary stress testing systems market. Furthermore, increasing incidences of lifestyle diseases coupled with heart and lung disorders are...Read More »
The global bioinformatics in IVD testing market is anticipated to witness growth over the forecast period. Factor such as the growing prevalence of cancer and other rare life-threatening disorders such as HIV, increased research and development, the cost-effectiveness of genomic sequence...Read More »
Tuberculosis is an infectious or sometimes fatal disease with mycobacteria its major cause. In common tuberculosis attacks the lungs, or even other parts of the body such as genitourinary system, lymphatic system, and central nervous system. Tuberculosis caused in lungs is known as Pulmo...Read More »
Point of care (POC) diagnosis refers to conducting diagnostic tests near the site of patient care. The Asia Pacific PoC diagnostics market is driven by four major factors namely growing geriatric population base in countries such as Japan and China, rising prevalence of target diseases, ... Read More »
April 2014The global advanced cancer diagnostics market is anticipated to grow significantly over the forecast period. Cancer or malignant neoplasm refers to a group of diseases caused by abnormal cell growth. This disease is marked by uncontrollable cell growth forming malignant tumors which inva...Read More »
The global endocrine function diagnostics market is anticipated to grow significantly over the forecast period. The endocrine system consists of a group of glands which produce and release hormones for the appropriate functioning of body functions. The most important function of these gl...Read More »
The global yersinia diagnostics market is anticipated to grow significantly over the forecast period. Yersinia is a gram-positive rod-shaped bacteria belonging to the Enterobacteriaceae family. Pathogenic species of Yersinia include Yersinia pestis, Yersinia enterocolitica and Yersinia p...Read More »
The global orthopedic extremity market is expected to witness lucrative growth over the forecast period owing to the rising global geriatric population base, coupled with increasing life expectancy rate. Rise in the incidence rate of sports injuries, the prevalence of obesity, and other ...Read More »
The global human papilloma virus testing market is expected to witness lucrative growth over the forecast period owing to the increasing prevalence of cervical cancer. The rise in the global geriatric female population is also one of the key drivers for market growth due to the presence ...Read More »
The global diagnostic electrocardiography devices market is expected to witness lucrative growth over the forecast period owing to increasing prevalence of cardiovascular diseases coupled with rising geriatric population base. Hence, the need for innovation in diagnostics for detection o...Read More »